CompletedNot Applicable

Botulinum Toxin Injection for Sialorrhea in Cerebral Palsy

Egypt61 participantsStarted 2021-06-30

Plain-language summary

A 100 units of botulinum toxin was injected in both parotid and submandibular glands for children (2 - 12 years) with incapacitating sialorrhea in juvenile cerebral palsy patients and they are followed up for 1 year

Who can participate

Age range4 Years – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Juvenile cerebral palsy with age range (4 - 12 years) * Having severe drooling (DFS \> 4) * Signing written informed consent by the legal guardians. Exclusion Criteria: * Previous BoNT-A injection in the last three months * Patients receiving systemic medicine for the treatment of sialorrhea in the last 6 weeks * Any contraindications to treatment with BoNT

What they're measuring

Drooling Severity Scale (DSS) and the Drooling Frequency Scale (DFS)

Timeframe: 1 year

Trial details

NCT IDNCT06101160

SponsorCairo University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-05-01

View on ClinicalTrials.gov More Sialorrhea trials